GR3006752T3 - - Google Patents

Info

Publication number
GR3006752T3
GR3006752T3 GR920403132T GR920403132T GR3006752T3 GR 3006752 T3 GR3006752 T3 GR 3006752T3 GR 920403132 T GR920403132 T GR 920403132T GR 920403132 T GR920403132 T GR 920403132T GR 3006752 T3 GR3006752 T3 GR 3006752T3
Authority
GR
Greece
Prior art keywords
aqueous solution
bismuth
citrate
product
potassium
Prior art date
Application number
GR920403132T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006752T3 publication Critical patent/GR3006752T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/29Antimony or bismuth compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR920403132T 1989-01-25 1993-01-08 GR3006752T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919172A IT1229502B (it) 1989-01-25 1989-01-25 Composizioni contenenti bismuto idonee per uso terapeutico.

Publications (1)

Publication Number Publication Date
GR3006752T3 true GR3006752T3 (el) 1993-06-30

Family

ID=11155495

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920403132T GR3006752T3 (el) 1989-01-25 1993-01-08

Country Status (10)

Country Link
US (1) US4965382A (el)
EP (1) EP0380950B1 (el)
JP (1) JPH02262534A (el)
AT (1) ATE84214T1 (el)
CA (1) CA2008068A1 (el)
DE (1) DE69000713T2 (el)
DK (1) DK0380950T3 (el)
ES (1) ES2052977T3 (el)
GR (1) GR3006752T3 (el)
IT (1) IT1229502B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
CN1055865C (zh) * 1995-10-30 2000-08-30 吴祁荃 X线结肠专用双对比造影剂
US6482865B1 (en) 2000-04-12 2002-11-19 Gastropal Partners Method for preparing colloidal solution of bismuth sodium tartrate
US6699912B2 (en) * 2000-04-12 2004-03-02 Gastropal Partners Method for preparing colloidal solution of bismuth sodium tartrate
RU2496719C1 (ru) * 2012-02-17 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут калий цитрата
RU2570610C1 (ru) * 2014-10-02 2015-12-10 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут аммоний цитрата
CN106632172A (zh) * 2016-12-28 2017-05-10 李玉成 枸橼酸抗坏血酸铋钾及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1536711A (en) * 1924-10-17 1925-05-05 Farbenfab Vorm Bayer F & Co Complex sodium bismuth salt of triglycollamic acid
US1663201A (en) * 1926-05-28 1928-03-20 Searle & Co Process for making bismuth tartrates and product produced thereby
US2054731A (en) * 1934-01-02 1936-09-15 Boots Pure Drug Co Ltd Organic salts of bismuth and process for producing same
US2232411A (en) * 1937-05-15 1941-02-18 George A Breon & Company Inc Bismuth hydroxylates of polyhydroxydicarboxylic acid salts
US2348984A (en) * 1942-06-25 1944-05-16 Robert A Lehman Sodium bismuth triglycollamate
US3840575A (en) * 1972-08-03 1974-10-08 Shirley Atkins Macclaren Bismuth subcompounds and their methods of preparation
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.

Also Published As

Publication number Publication date
IT1229502B (it) 1991-09-03
EP0380950A3 (en) 1990-12-27
IT8919172A0 (it) 1989-01-25
EP0380950B1 (en) 1993-01-07
DK0380950T3 (da) 1993-02-08
CA2008068A1 (en) 1990-07-25
US4965382A (en) 1990-10-23
EP0380950A2 (en) 1990-08-08
DE69000713D1 (de) 1993-02-18
DE69000713T2 (de) 1993-05-06
JPH02262534A (ja) 1990-10-25
ATE84214T1 (de) 1993-01-15
ES2052977T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
AU582920B2 (en) Continuous release pharmaceutical compositions
GR3006752T3 (el)
AU586316B2 (en) Derivatives of cis, endo-2-azabicyclo-(3.3.0)-octane-3- carboxylic acid and a process for their preparation
EP1181929A3 (en) Method of potentiating an immune response and compositions therefor
NZ230005A (en) Solid, porous unitary form prepared by lyophilising a paste comprising micro- and/or nano-particles
FI91936C (fi) Menetelmä kiinteän lääkevalmisteen valmistamiseksi
MY104055A (en) Furan derivatives.
EP0334507A3 (en) Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid
EP0251542A3 (en) Oral composition
HUT40804A (en) Process for production of medical preparatives containing n-acetyl neuramin acid
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
HUT44908A (en) Fungicides comprising triazolyl- or imidazolyl-group-substituted 2,5-dihydrofuran derivatives as active ingredient and process for producing the active ingredient and intermediaries thereof
EP0285856A3 (en) Use of dihydroergotamine and its salts in the local treatment of trophic disorders
EP0409559A3 (en) Pharmaceutical and dietary uses of fatty acids
EP0207505A3 (en) Use of a prenyl ketone in the preparation of a medicament against gastritis
JPS545097A (en) Preparation of immobilized glucose isomerase
JPS5296745A (en) Aqueous agent for immunity control
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
EP0210470B1 (en) Process for the preparation of 1-pyrazolines
IT1194204B (it) Procedimento per realizzare o migliorare l'assistenza respiratoria e relativa apparecchiatura
JPS545913A (en) Preparation of pantethine
CA2022372A1 (en) Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
JPS5369875A (en) Preparation of luminous body contg. luminous bacteria
HUT48101A (en) Insecticides and acaricides comprising 2,2-dimethyl cyclopropanecarboxylic acid derivatives as active ingredient and process for producing the active ingredient
EP0134485A3 (de) 5-Cyclopropyl-5,8-dihydro-8-oxo-1,3-dioxolo-(4,5-g) chinolin-7-carbonsäure, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakerielle Mittel